InvestorsObserver is giving Boston Scientific Corporation (BSX) an Analyst Rating Rank of 71, meaning BSX is ranked higher by analysts than 71% of stocks. The average projection by analysts for BSX is $45.722 over the next 12 months and analyst’s classify the stock as a Strong Buy
Why are Analyst Ratings Important?
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.
InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.
What's Happening With Boston Scientific Corporation Stock Today?
Boston Scientific Corporation (BSX) stock is lower by -0.56% while the S&P 500 has risen 0.63% as of 2:33 PM on Friday, Oct 16. BSX is down -$0.22 from the previous closing price of $39.00 on volume of 7,645,428 shares. Over the past year the S&P 500 has risen 16.92% while BSX has risen 1.60%. BSX earned $2.82 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 13.77.
Click Here to get the full report on Boston Scientific Corporation (BSX) Stock.
